From Financial Modeling Prep: 2025-02-04 09:33:00

Merck & Co (NYSE:MRK) stock dropped 8% in pre-market trading due to mixed Q4 results. Earnings missed at $1.72 EPS, revenue beat at $15.6 billion, up 7% YoY. Full-year guidance of $8.88-$9.03 EPS and $64.1-$65.6 billion revenue fell short of expectations. 2024 sales hit $64.2 billion, up 7% annually, driven by KEYTRUDA’s 18% sales growth to $29.5 billion.



Read more at Financial Modeling Prep:: Merck Shares Plunge 8% as Weak Guidance Overshadow…